Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2002-01-29
2008-11-04
Chernyshev, Olga N (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388240, C530S387100, C424S130100, C424S139100, C424S141100, C424S145100, C435S007100, C435S007500, C435S007700, C435S007900, C435S007920
Reexamination Certificate
active
07446180
ABSTRACT:
Invention relates to antibodies with a specificity to an abnormally truncated form of tau protein which is conformationally different from normal tau and does not bind to normal tau protein, conformationally different tau proteins (“tauons”) and diagnostic and therapeutical aspects in relation to Alzheimer's disease and related tauopathies.
REFERENCES:
patent: 5733734 (1998-03-01), Trojanowski et al.
patent: WO 94/18560 (1994-02-01), None
patent: WO 02/062851 (2002-08-01), None
Ksiezak-Reding et al., 1988 (J. Biol. Chemistry,, vol. 263, No. 17, pp. 7943-7947).
Abraha et al., “C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease,”Journal of Cell Science, 113:3737-3745, 2000.
Black, “Comparison of the effects of microtubule-associated protein 2 and tau on the packing density of in vitro assembled mirotubles,”Proc. Natl. Acad. Sci., USA, 84(21):7783-7787, 1987.
Blessed et al., “The association between quantitative measures of demetia and of senile cahnge in the cerebral grey matter of elderly subjects,”Brit. J. Psychiat., 114:797-811, 1968.
Blum et al., “Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels,”Electrophoresis, 8:93-99, 1987.
Cleveland et al., “Physical and chemical properties of purified tau factor and the role of tau in microtube assembly,”J. Mol. Biol., 116:227-247, 1977.
Cleveland et al., “Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin,”J. Mol. Biol., 116:207-225, 1977.
Cote et al., “Current protocols for light microscopy immunocytochemistry,”Immunohistochemistry II, A. C. Cuelllo (ed.), John Wiley & Sons., 147-168, 1993.
Crowther et al., “Assembly of Alzheimer-like filaments from full-length tau protein,”FEBS Letters, 337:135-138, 1994.
Dickson et al., “Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and Corticobasal Degenration,”J. Neural Transm., (Supp.)47:31-46, 1996.
DiFiglia et al., “Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain,”Science, 277:1990-1993, 1997.
Donofrio et al., “Electroelution for purification of influenza A matrix protein for use in immunoassay,”Journal of Virological Methods, 13:107-120, 1986.
Drewes et al., “MAP's, MARK's and microtubule dynamics,”TIBS, 23:307-311, 1998.
Drubin and Kirschner, “Tau protein function in living cells,”The Journal of Cell Biology, 103:2739-2746, 1986.
Fasulo et al., “Overexpression of Alzheimer's PHF core tau fragments: implications for the tau truncation hypothesis,”Alzheimer's Research, 2:195-200, 1996.
Forno, “The Lewy body in Parkinson's Disease,”Advances in Neurology, 45:35-43, 1986.
Goedert et al., “Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans,”Nature, 383, 550-553, 1996.
Goedert et al., “Multiple isoforms of human microtubule-assocaited protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's Disease,”Neuron, 3:519-526, 1989.
Greenberg and Davies, “A preparation of Alzheimer paired helical filaments that displays distinct τ proteins by polyacrylamide gel electrophoresis,”Proc. Natl. Acad. Sci., USA, 87:5827-5831, 1990.
Grundke-Iqbal et al., “Abnormal phosphorylation of the microtubule-associated protein $\tau $ (Tau) in Alzheimer cytoskeletal pathology,”Proc. Natl. Acad. Sci., USA, 83(13):4913-4917, 1986.
Gustke et al., “The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro an dThr-Pro motifs,”FEBS, 307(2):199-205, 1992.
Himmler, “Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family,”Molecular and Cellular Biology, 9(4):1389-1396, 1989.
Hirano and Zimmerman, “Alzheimer's neurofibrillary changes,”Archives of Neurology, 7:227-242, 1962.
Jicha et al., “Sequnce requirements for formation of conformational variants of tau similar to those found in Alzheiner's disease,”Journal of Neuroscience Research, 55:713-723, 1999.
Kampers et al., “RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments,”FEBS Letters, 399:344-349, 1996.
Kenessy et al., “Detection of o-asparate in tau proteins associated with Alzheimer paired helical filaments,”Brain Research, 675:183-189, 1995.
Kiss et al., “Light microscopic triple-colored immunohistochemical staining on the same vibratome section using the avidin-botin-perioxidase complex technique,”Histochemistry, 88:353-356, 1988.
Ko et al., “An Immunochemical study on tau glycation in paired helical filaments,”Brain Research, 830:301-313, 1999.
Kontsekova et al., “Quick purification of recombinant human truncated tau proteins for immunoanalysis,”Journal of Immunological Methods, 185:245-248, 1995.
Kontsekova et al., “The effect of postfusion cell density on establishment of hybridomas,”Folia Biologica, 34:19-22, 1988.
Kontsekova, et al., “One-step method for establishing 8-azaguanine-resistant hybridomas suitable for the preparation of triomas,”Journal of Immunological Methods, 145:247-250, 1991.
Kopke et al., “Microtubule-associated protein tau,”The Journal of Biological Chemistry, 268(32):24374-24384, 1993.
Kosik et al., “Develpmentally regulated expression of specific tau sequences,”Neuron, 2:1389-1397, 1989.
Ksiezak-Reding et al., “Assembed tau filaments differ from native paired helical filaments as determined by scanning transmission electrom microscopy (STEM),”Brain Research, 814:86-98, 1998.
Laemmli, “Cleavage of structural proteins durin the assembly of the head of bacteriophage T4,”Nature, 227:680-685, 1970.
Lindwall and Cole, “The purification of tau protein and the occurance of two phosphorylation states of tau in brain,”The Journal of Biological Chemistry, 259(19):12241-12245, 1984.
LoPresti et al., “Functional implications for the mircotubule-associated protein tau: localization in oligodendrocytes,”Proc. Natl. Acad. Sci., USA, 92:10369-10373, 1995.
Mori et al., “Ubiquitin is a component of paired helical filaments in Alzheimer's isease,”Science, 235:1641-16441987.
Nishimura et al., “Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy,”Neuroscience Letters, 201:123-126, 1995.
Novak et al., “Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitome analysis of monoclonal antibodies 423 and 7.51,”Proc. Natl. Acad. Sci., USA, 88:5837-5841, 1991.
Novak et al., “Molecular characterization of minimal protease resistant tau unit of the Alzheimer's disease paired helical filament,”EMBO Journal, 12(1):365-370, 1993.
Novak, “Truncated tau protein as a new marker for Alzheimer's disease,”Acta Virology, 38(3):173-189, 1994.
Paudel and Li, “Heparin-induced conformational change in microtubule-associated protein tau a s detected by chemical cross-linking and phosphopeptide mapping,”The Journal of Biological Chemistry, 274(12):8029-8038, 1999.
Perez et al., “Polymerization of τ into filaments in the prescence of heparin: the inimal sequence requred for τ-τ interation,”Journal of Neurochemistry, 67:1183-1190, 1996.
Prusiner,Human prion diseases and neurodegeneration, Ed Springer-Verlag, Berlin, 1996.
Reed et al., “The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia,”Journal of Neuropathology and Experiment
Axon Neuroscience Forschungs-Und Entwicklungs GmbH
Chernyshev Olga N
Fulbright & Jaworski LLP
LandOfFree
Conformationally abnormal forms of tau proteins and specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conformationally abnormal forms of tau proteins and specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conformationally abnormal forms of tau proteins and specific... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4032538